Format

Send to

Choose Destination
Isr Med Assoc J. 2008 Mar;10(3):232-4.

Mesenchymal stromal cells: a novel treatment option for steroid-induced avascular osteonecrosis.

Author information

1
Department of Hematology, Oncology and General Pediatrics, University Children's Hospital, Tuebingen, Germany. nikolay.tzaribachev@med.uni-tuebingen.de

Abstract

Mesenchymal stromal cells are multipotent cells capable of tissue repair and immune modulation. They are primarily found in bone marrow, but are also present in other tissues of mesenchymal origin, such as fatty tissue, muscle, tendons, etc. MSC can easily be obtained by bone marrow aspiration, showing a rapid expansion in vitro. New protocols enable cell culture without the use of animal-derived sera and artificial growth factors. Avascular necroses of the bone may have different causes. AVN in autoimmune and hematological diseases show a strong association with corticosteroid treatment, which is often unavoidable in severe cases. Until recently, core decompression of the affected osseous area was the standard approach. Because of their differentiation properties, easy accessibility and proliferative capacity, autologous MSCs could potentially complement AVN treatment by adding fresh "osteogenic cells" to the healing process.

PMID:
18494240
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Israel Medical Association
Loading ...
Support Center